Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland

BMC Molecular Biology

Volumn 11, Issue , 2010, Pages

  Escamilla Hernandez, Rosalba ^a   Chakrabarti, Rumela ^a   Romano, Rose Anne ^a   Smalley, Kirsten ^a   Zhu, Qianqian ^a   Lai, William ^a   Halfon, Marc S ^a   Buck, Michael J ^a   Sinha, Satrajit ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; PROTEIN ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF5; TRANSCRIPTION FACTOR ELF5 ANTIBODY; UNCLASSIFIED DRUG; CCND2 PROTEIN, MOUSE; DNA BINDING PROTEIN; ELF5 PROTEIN, MOUSE; HYBRID PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC IDENTIFICATION; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MAMMARY GLAND; MOLECULAR CLONING; MORPHOGENESIS; MOUSE; NONHUMAN; PREGNANCY; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; GENETICS; GENOME; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REGULATORY SEQUENCE; UDDER;

MUS;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D2; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PREGNANCY; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS;

EID: 77956455343     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-11-68     Document Type: Article

References (37)

1. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003, 303:11-34. 10.1016/S0378-1119(02)01156-3, 12559563.
2. Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 2004, 279(12):11281-11292. 10.1074/jbc.M311887200, 14662758.
3. Turner DP, Findlay VJ, Moussa O, Watson DK. Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem 2007, 102(3):549-559. 10.1002/jcb.21494, 17661355.
4. He J, Pan Y, Hu J, Albarracin C, Wu Y, Dai JL. Profile of Ets gene expression in human breast carcinoma. Cancer Biol Ther 2007, 6(1):76-82.
5. Zhou J, Ng AY, Tymms MJ, Jermiin LS, Seth AK, Thomas RS, Kola I. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines. Oncogene 1998, 17(21):2719-2732. 10.1038/sj.onc.1202198, 9840936.
6. Oettgen P, Kas K, Dube A, Gu X, Grall F, Thamrongsak U, Akbarali Y, Finger E, Boltax J, Endress G, et al. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J Biol Chem 1999, 274(41):29439-29452. 10.1074/jbc.274.41.29439, 10506207.
7. Zhou J, Chehab R, Tkalcevic J, Naylor MJ, Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S, Xu D, et al. Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. Embo J 2005, 24(3):635-644. 10.1038/sj.emboj.7600538, 548648, 15650748.
8. Donnison M, Beaton A, Davey HW. Broadhurst R, L'Huillier P, Pfeffer PL: Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning. Development 2005, 132(10):2299-2308. 10.1242/dev.01819, 15829518.
9. Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL, et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 2008, 22(5):581-586. 10.1101/gad.1614608, 2259028, 18316476.
10. Choi YS, Chakrabarti R, Escamilla-Hernandez R, Sinha S. Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev Biol 2009, 329(2):227-241. 10.1016/j.ydbio.2009.02.032, 19269284.
11. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, et al. Gene expression profiles of human breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(10):5974-5979. 10.1073/pnas.0931261100, 156311, 12714683.
12. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 2008, 26(2):364-371. 10.1634/stemcells.2007-0440, 17975224.
13. Choi YS, Sinha S. Determination of the consensus DNA-binding sequence and a transcriptional activation domain for ESE-2. Biochem J 2006, 398(3):497-507. 10.1042/BJ20060375, 1559455, 16704374.
14. Yaniw D, Hu J. Epithelium-specific ets transcription factor 2 upregulates cytokeratin 18 expression in pulmonary epithelial cells through an interaction with cytokeratin 18 intron 1. Cell Res 2005, 15(6):423-429. 10.1038/sj.cr.7290310, 15987600.
15. Nguyen J, Yamada D, Schultz DC, Defossez PA. Assessment of sera for chromatin-immunoprecipitation. Biotechniques 2008, 44(1):66. 68, 10.2144/000112681, 18254381.
16. Birkaya B, Ortt K, Sinha S. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach. BMC Mol Biol 2007, 8:43. 10.1186/1471-2199-8-43, 1890296, 17521434.
17. Farnham PJ. Insights from genomic profiling of transcription factors. Nat Rev Genet 2009, 10(9):605-616. 10.1038/nrg2636, 2846386, 19668247.
18. Rubins NE, Friedman JR, Le PP, Zhang L, Brestelli J, Kaestner KH. Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2. Mol Cell Biol 2005, 25(16):7069-7077. 10.1128/MCB.25.16.7069-7077.2005, 1190247, 16055718.
19. Wederell ED, Bilenky M, Cullum R, Thiessen N, Dagpinar M, Delaney A, Varhol R, Zhao Y, Zeng T, Bernier B, et al. Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing. Nucleic Acids Res 2008, 36(14):4549-4564. 10.1093/nar/gkn382, 2504304, 18611952.
20. Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, Kang YA, Choi K, Farnham PJ, Bresnick EH. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 2009, 36(4):667-681. 10.1016/j.molcel.2009.11.001, 19941826.
21. Kong G, Chua SS, Yijun Y, Kittrell F, Moraes RC, Medina D, Said TK. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development. Oncogene 2002, 21(47):7214-7225. 10.1038/sj.onc.1205895, 12370811.
22. Wang Y, Feng L, Said M, Balderman S, Fayazi Z, Liu Y, Ghosh D, Gulick AM. Analysis of the 2.0 A crystal structure of the protein-DNA complex of the human PDEF Ets domain bound to the prostate specific antigen regulatory site. Biochemistry 2005, 44(19):7095-7106. 10.1021/bi047352t, 15882048.
23. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 2001, 61(6):2782-2787.
24. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004, 6(2):R75-91. 10.1186/bcr753, 400652, 14979920.
25. Hochegger H, Takeda S, Hunt T. Cyclin-dependent kinases and cell-cycle transitions: does one fit all?. Nat Rev Mol Cell Biol 2008, 9(11):910-916. 10.1038/nrm2510, 18813291.
26. Susaki E, Nakayama K, Nakayama KI. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition. Mol Cell Biol 2007, 27(13):4626-4640. 10.1128/MCB.00862-06, 1951473, 17452458.
27. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009, 15(8):907-913. 10.1038/nm.2000, 19648928.
28. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008, 3(1):109-118. 10.1016/j.stem.2008.05.018, 18593563.
29. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 2001, 15(16):2042-2047. 10.1101/gad.907901, 312761, 11511535.
30. Martino A, Holmes J, Lord JD, Moon JJ, Nelson BH. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol 2001, 166(3):1723-1729.
31. Rojas A, Kong SW, Agarwal P, Gilliss B, Pu WT, Black BL. GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol Cell Biol 2008, 28(17):5420-5431. 10.1128/MCB.00717-08, 2519727, 18591257.
32. Yamaji D, Na R, Feuermann Y, Pechhold S, Chen W, Robinson GW, Hennighausen L. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 2009, 23(20):2382-2387. 10.1101/gad.1840109, 2764497, 19833766.
33. Sripathy SP, Stevens J, Schultz DC. The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression. Mol Cell Biol 2006, 26(22):8623-8638. 10.1128/MCB.00487-06, 1636786, 16954381.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
35. Romano RA, Birkaya B, Sinha S. A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. J Invest Dermatol 2007, 127(5):1175-1186. 10.1038/sj.jid.5700652, 17159913.
36. Ortt K, Sinha S. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. FEBS Lett 2006, 580(18):4544-4550. 10.1016/j.febslet.2006.07.004, 16870177.
37. Tummala R, Romano RA, Fuchs E, Sinha S. Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family. Gene 2003, 321:93-102. 10.1016/S0378-1119(03)00840-0, 14636996.